Blood testing has been their cash cow.

On March 1, we had to turn away over 100 students. We promised them we would arrange another testing, and we are keeping that promise.

There are lots of other places to cut costs, including direct-to-consumer advertising. But even with a radical restructuring, Pfizer will need multiple new blockbusters to make up for shrinking sales of drugs losing patent protection -- and doesn't have them.

Maybe yesterday's events will light a fire under Pfizer to do some major restructuring beyond their ongoing efforts.

We've had it for a few months. We're testing it to see the effectiveness.

Some companies have terminated drug testing.